US Stock MarketDetailed Quotes
TEVA Teva Pharmaceutical Industries
- 17.101
- -0.329-1.89%
Trading Aug 12 14:13 ET
19.37BMarket Cap-43847P/E (TTM)
17.360High17.020Low3.16MVolume17.320Open17.430Pre Close54.49MTurnover0.28%Turnover RatioLossP/E (Static)1.13BShares18.02552wk High3.05P/B19.25BFloat Cap8.05552wk Low--Dividend TTM1.13BShs Float68.007Historical High--Div YieldTTM1.95%Amplitude3.107Historical Low17.229Avg Price1Lot Size
Teva Pharmaceutical Industries Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.40%4.16B | 4.29%3.82B | 6.16%15.85B | 14.78%4.46B | 7.09%3.85B | 2.43%3.88B | 0.03%3.66B | -6.01%14.93B | -5.29%3.88B | -7.49%3.6B |
| Operating revenue | 7.61%4.06B | 3.67%3.7B | 5.37%15.28B | 9.85%4.21B | 8.02%3.73B | 2.50%3.77B | 0.99%3.57B | -5.74%14.5B | -3.99%3.83B | -7.99%3.46B |
| Cost of revenue | 2.79%2.14B | -1.49%2.05B | 3.12%8.2B | -3.41%2.04B | 3.79%2B | 4.52%2.08B | 8.22%2.08B | -4.01%7.95B | 3.07%2.11B | -7.98%1.93B |
| Gross profit | 12.69%2.02B | 11.95%1.77B | 9.64%7.65B | 36.44%2.42B | 10.90%1.85B | 0.11%1.8B | -9.08%1.58B | -8.18%6.97B | -13.66%1.77B | -6.97%1.67B |
| Operating expense | 5.04%1.21B | 5.12%1.13B | 3.92%4.45B | 3.26%1.17B | 9.35%1.09B | 4.45%1.15B | 1.99%1.07B | -4.72%4.28B | -7.35%1.14B | -8.29%995M |
| Selling and administrative expenses | 3.19%939M | 5.23%886M | 1.54%3.5B | 7.77%902M | 2.68%844M | 0.33%910M | -4.32%842M | -2.35%3.45B | -7.82%837M | -7.43%822M |
| -Selling and marketing expense | 8.79%656M | 11.36%608M | 3.13%2.34B | 11.11%610M | 6.86%576M | 1.52%603M | -6.51%546M | -6.75%2.27B | -13.00%549M | -9.72%539M |
| -General and administrative expense | -7.82%283M | -6.08%278M | -1.53%1.16B | 1.39%292M | -5.30%268M | -1.92%307M | 0.00%296M | 7.37%1.18B | 3.97%288M | -2.75%283M |
| Research and development costs | 12.08%269M | 3.42%242M | 13.72%953M | 8.10%227M | 44.57%253M | 5.26%240M | 4.00%234M | -13.34%838M | -13.93%210M | -21.17%175M |
| Other operating expenses | ---- | 150.00%1M | ---- | ---- | -350.00%-9M | ---- | 96.15%-2M | ---- | ---- | 92.00%-2M |
| Operating profit | 26.32%816M | 26.38%642M | 18.74%3.19B | 95.75%1.24B | 13.20%763M | -6.78%646M | -26.06%508M | -13.20%2.69B | -23.03%635M | -4.94%674M |
| Net non-operating interest income expense | 10.07%-241M | 3.85%-250M | -10.49%-1.1B | -6.30%-287M | -11.11%-280M | -27.01%-268M | -0.78%-260M | -3.01%-991M | -71.97%-270M | -4.56%-252M |
| Non-operating interest expense | -10.07%241M | -3.85%250M | 10.65%1.03B | 5.74%221M | 11.11%280M | 27.01%268M | 0.78%260M | 4.38%930M | 143.02%209M | 4.56%252M |
| Total other finance cost | ---- | ---- | 8.20%66M | ---- | ---- | ---- | ---- | -14.08%61M | ---- | ---- |
| Other net income (expense) | 36.77%-822M | -64.88%-859M | 43.96%-2.72B | 68.99%-484M | -59.61%-407M | 20.88%-1.3B | 62.79%-521M | -228.31%-4.86B | -84.73%-1.56B | -196.51%-255M |
| Gain on sale of security | ---- | ---- | 46.15%38M | ---- | ---- | ---- | ---- | 126.80%26M | ---- | ---- |
| Special income (charges) | 37.84%-823M | -71.29%-877M | 43.47%-2.75B | 66.77%-529M | -59.45%-405M | 19.02%-1.32B | 62.87%-512M | -256.23%-4.86B | -109.20%-1.59B | -191.95%-254M |
| -Less：Restructuring and merger&acquisition | 138.64%210M | 1.10%92M | 61.92%659M | 142.11%460M | 38.71%43M | -8.33%88M | 1.11%91M | 190.71%407M | 272.55%190M | -16.22%31M |
| -Less:Impairment of capital assets | -31.52%530M | 261.17%679M | -55.95%1.08B | -95.29%68M | 71.43%48M | -4.44%774M | 13.94%188M | 319.01%2.45B | 689.62%1.45B | -40.43%28M |
| -Less:Other special charges | -82.03%83M | -54.51%106M | -49.83%1.04B | 38.10%29M | 61.03%314M | -36.63%462M | -79.27%233M | 196.42%2.07B | -96.41%21M | 6,400.00%195M |
| -Gain on sale of business | ---- | ---- | -93.48%3M | ---- | ---- | ---- | ---- | -9.80%46M | ---- | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | 38.89%25M | ---- | ---- | ---- | ---- | 157.14%18M | ---- | ---- |
| Other non- operating income (expenses) | -95.83%1M | 300.00%18M | 46.15%-14M | 40.00%7M | -100.00%-2M | 400.00%24M | 57.14%-9M | -36.84%-26M | -61.54%5M | -200.00%-1M |
| Income before tax | 73.35%-246M | -71.69%-467M | 80.27%-624M | 139.45%473M | -54.82%75M | 20.43%-923M | 71.99%-272M | -580.70%-3.16B | -585.14%-1.2B | -56.54%166M |
| Income tax | 4,037.50%630M | -173.68%-52M | 98.91%-7M | -72.48%41M | -111.21%-12M | 98.22%-16M | -1,050.00%-19M | -404.74%-643M | 720.83%149M | 40.79%107M |
| Earnings from equity interest net of tax | 100.00%2M | ---4M | -90.48%2M | 0.00%1M | ---- | --1M | ---- | 133.33%21M | --1M | 80.00%-1M |
| Net income | 3.53%-874M | -65.61%-419M | 75.39%-615M | 132.15%433M | 51.72%88M | -249.81%-906M | 73.42%-253M | -648.03%-2.5B | -786.18%-1.35B | -80.79%58M |
| Net income continuous Operations | 3.53%-874M | -65.61%-419M | 75.39%-615M | 132.15%433M | 50.00%87M | -248.46%-906M | 73.42%-253M | -648.03%-2.5B | -792.05%-1.35B | -80.73%58M |
| Minority interest income | 17.14%-29M | -748.48%-280M | -5.66%-56M | 112.50%4M | 166.67%8M | -29.63%-35M | -1,200.00%-33M | -235.90%-53M | -557.14%-32M | -72.73%3M |
| Net income attributable to the parent company | 2.98%-846M | 36.82%-139M | 77.15%-559M | 132.65%429M | 42.86%80M | -275.86%-872M | 76.96%-220M | -686.57%-2.45B | -726.42%-1.31B | -80.82%56M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 2.98%-846M | 36.82%-139M | 77.15%-559M | 132.65%429M | 42.86%80M | -275.86%-872M | 76.96%-220M | -686.57%-2.45B | -726.42%-1.31B | -80.82%56M |
| Basic earnings per share | 3.85%-0.75 | 40.00%-0.12 | 77.27%-0.5 | 137.27%0.41 | 40.00%0.07 | -271.43%-0.78 | 76.74%-0.2 | -678.95%-2.2 | -685.71%-1.1 | -80.77%0.05 |
| Diluted earnings per share | 3.85%-0.75 | 40.00%-0.12 | 77.27%-0.5 | 137.27%0.41 | 40.00%0.07 | -271.43%-0.78 | 76.74%-0.2 | -678.95%-2.2 | -685.71%-1.1 | -80.77%0.05 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
